The Park Medi World IPO is worth ₹920 Cr and a book-built issue comprising 4,75,30,864 fresh equity shares worth ₹770 Cr and 92,59,259 offer-for-sale shares worth ₹150 Cr.
The issue is available for bidding starting from 10 December 2025, and it lasts until 12 December 2025. The allotment is tentatively set on 15 December 2025, while the listing of shares is expected on 17 December 2025, on the platforms BSE and NSE.
The Park Medi World IPO price range has been fixed between ₹154 and ₹162 per share. The retail investors need to bid for at least 92 shares, requiring a minimum investment of ₹14,904. The application size requirements for the sNII are 14 lots, 1,288 shares, making a minimum investment of ₹2,08,656, and the bNII needs to bid for 68 lots, 6,256 shares, which comes to ₹10,13,472.
Park Medi World IPO Details
Here are the Park Medi World IPO details in India for the investors:
| Bid Opens On | 10 December 2025 |
| Bid Closes On | 12 December 2025 |
| Face Value | ₹2 |
| Price Band | ₹154 and ₹162/share |
| Issue Price | – |
| IPO Lot Size | 92 Shares |
| Type of Sale | Fresh issue & Offer-for-sale |
| Offer for Sale | 92,59,259 shares (₹150 Cr) |
| Fresh Issue | 4,75,30,864 shares ( ₹770 Cr) |
| Issue Type | Book-built Mainboard IPO |
| Listing | BSE & NSE |
| Total Issue Size (₹ Cr) | 5,67,90,123 shares (₹920 Cr) |
| Reservation for Market Maker | – |
| Net Offered to the Public | – |
| Minimum Investment(₹) | ₹14,904 |
| Retail Discount | – |
| Employee Discount | – |
Park Medi World IPO Timeline
Check out the complete timeline for the Park Medi World IPO:
| Bidding Opens | 10 December 2025 |
| Bidding Closes | 12 December 2025 |
| Shares Allotment | 15 December 2025 |
| Initiation of Refunds | 16 December 2025 |
| Shares Credited to demat | 16 December 2025 |
| Listing Date | 17 December 2025 |
| UPI Mandate Confirmation Deadline | 5 PM, 12 December 2025 |
Park Medi World Limited Key Performance Indicator
Check the Park Medi World’s key performance indicators over its past three financial years.
| KPIs | 2025 | 2024 | 2023 |
| ROE (%) | 20.68 | 18.25 | 35.82 |
| ROCE (%) | 17.47 | 16.07 | 26.78 |
| Debt-Equity Ratio (in times) | 0.61 | 0.73 | 0.79 |
| RoNW (%) | 20.08 | 18.81 | 32.91 |
| PAT Margin (%) | 15.3 | 12.35 | 18.19 |
| EBITDA Margin (%) | 26.71 | 25.21 | 31.11 |
| Price-Book Value | – | – | – |
Park Medi World Ltd. Financials
| Aspect | 2025 (₹ Cr) | 2024 (₹ Cr) | 2023 (₹ Cr) |
| Revenue | 1,393.57 | 1,231.07 | 1,254.60 |
| Total Asset | 2,133.70 | 1,912.10 | 1,592.82 |
| Profit/Loss | 213.22 | 152.00 | 228.17 |
Park Medi World IPO: Grey Market Premium
Park Medi World IPO GMP today remains at ₹0. A rising GMP signals a better market mood and growing investor interest in the IPO.
| Date | GMP (₹) | Estimated Listing Price | Estimated Listing Gain | Trend |
| 27 November 2025 | ₹0 | ₹162 | (0.00%) | – |
| 26 November 2025 | ₹0 | ₹ | (0.00%) | – |
Note: An IPO GMP isn’t fixed and keeps shifting with demand and market sentiment before the IPO hits the market.
Park Medi World IPO Reservation
Park Medi World IPO shares are divided among different investor groups as shown below.
| Category | % of Shares Offered | Shares offered |
| QIBs | Maximum 50% | – |
| Retail Investors | Minimum 35% | – |
| NII (HNI) | Minimum 15% | – |
| Total Shares Offered | 100% | – |
Park Medi World IPO Lot Size
The table shows the minimum investment needed for each category and the Park Medi World IPO lot size.
| Application | Lot Size | Shares | Amount(in ₹) |
| Minimum Retail Investors | 1 | 92 | 14,904 |
| Maximum Retail Investors | 13 | 1,196 | 1,93,752 |
| S-HNI (Minimum) | 14 | 1,288 | 2,08,656 |
| S-HNI (Maximum) | 67 | 6,164 | 9,98,568 |
| B-HNI (Minimum) | 68 | 6,256 | 10,13,472 |
Park Medi World IPO Anchor Investors Details
Here’s how the Park Medi World IPO has allocated shares for anchor investors:
| Bidding Date | 9 December 2025 |
| Offered Shares | – |
| Anchor Investor Portion Size (₹ Cr.) | – |
| Lock-in period of 30-Day for 50% of the shares | – |
| Lock-in period of 90-Day for the remaining shares | – |
Park Medi World IPO Prospectus
Check the official Park Medi World IPO filings submitted to SEBI for complete details.
Park Medi World Limited: About
| Founded in | 20 January 2011 |
| Managing Director | Dr. Ankit Gupta |
| Services/Products Offered | Hospital chain |
| Book running lead managers | Nuvama Wealth Management Ltd., CLSA India Private Ltd., DAM Capital Advisors Ltd., & Intensive Fiscal Services Private Ltd. |
| Registrar of the issue | Kfin Technologies Ltd. |
Park Medi World IPO: Objectives
Park Medi World Ltd. has outlined the use of its IPO proceeds as shown below.
| Particulars | Amount (in ₹ Cr) |
| Payment of borrowings | 380.00 |
| Funding for development of new hospital | 60.50 |
| Funding for purchase of medical equipment | 27.46 |
| Acquisitions and other corporate needs | – |
Park Medi World Ltd.: Strengths
- Market position: The company ranks as the second largest chain in the private hospital networks in North India and leads the sector in Haryana.
- Wide and affordable care: The company delivers a range of medical specialties at prices aimed to stay accessible for most patients.
- Proven expansion strategy: The company has consistently taken over hospitals and blended them smoothly into its network.
- Stable business performance: The company’s operations and finances remain strong, supported by a healthy mix of different payor sources.
Park Medi World Ltd.: Risks
- Contingent liabilities impact: The company has contingent liabilities, and they can affect the company’s cash flow and overall financial health in the future.
- Revenue fall & rising costs: The company’s earnings dropped in 2024 while expenses went up, and if this trend continues, it could reduce profitability and affect the company’s finances.
- Dependence on medical staff: The company depends on healthcare professionals, and high attrition, 33.72% as of Sept 2025, may weaken operations if hiring or retention fails.
- Regulatory & licensing risks: If the company fails to secure required approvals and renewals, including accreditations, it may disrupt operations and impact financial performance.
Park Medi World IPO Review
Park Medi World operates one of North India’s major private hospital networks, backed by consistent margins, low debt, and strong demand for healthcare services. Its expansion through acquisitions suggests long-term growth prospects.
However, its declining revenue and high doctor attrition remain concerns. The investors should assess the business strengths and risks before taking a position.
Other Recent IPO List
Here’s a list of upcoming and recently opened Indian IPOs in 2025 for you to check out:
| Corona Remedies IPO | Vidya Wires IPO |
| Luxury Time IPO | Aequs IPO |
| Method Software IPO | Helloji Holidays IPO |
| Wakefit Innovations IPO | Neochem Bio IPO |
Park Medi World IPO FAQs
The Park Medi World IPO is a ₹920 crore mainboard IPO that includes both a fresh issue of ₹770 crore and an offer-for-sale of ₹150 crore. The company runs a large hospital chain across North India, offering a mix of medical specialities. Its shares are going to be listed on the NSE and BSE.
The investors can make the applications online through broker platforms or through UPI-supported apps, using the ASBA facility provided by banks. They must select the lot size, approve the UPI mandate, and wait for the allotment announcement.
Park Medi World Ltd. shows strong market presence, expansion experience, and steady margins. At the same time, rising costs, declining revenue, and talent retention risks may affect performance. The investment decisions should measure growth against these operational concerns.
The Park Medi World IPO has no fixed return expectation. The GMP currently stands at ₹0, showing no early listing premium. Returns depend on market conditions, demand during subscription, and the company’s ability to maintain financial growth after listing.
The Park Medi World IPO bidding window opens on 10 December 2025 and closes on 12 December 2025. UPI mandates must be confirmed before 5 PM on the closing day.
The Park Medi World IPO’s minimum bid size is 92 shares, requiring ₹14,904 for retail investors. Higher categories like sNII and bNII need larger lot multiples based on the category requirements.
The allotment for the Park Medi World IPO is scheduled for 15 December 2025. Refunds and demat credits are likely to take place on 16 December 2025, after which investors can check their allotment status through the registrar.
The shares of Park Medi World IPO are expected to list on 17 December 2025 on both the BSE and NSE, subject to market and regulatory timelines.
